E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway

• Published in: Cancer research (Chicago, Ill.) Ill.), 1996-10, Vol.56 (20), p.4620-4624
• Main Authors: BOYER, S. N, WAZER, D. E, BAND, V
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Breast - cytology; Breast - metabolism; Carcinogenesis, carcinogens and anticarcinogens; Cell Line, Transformed; Cysteine Endopeptidases - metabolism; Epithelial Cells; Epithelium - metabolism; Female; Humans; Medical sciences; Multienzyme Complexes - metabolism; Oncogene Proteins, Viral - metabolism; Oncogene Proteins, Viral - physiology; Papillomavirus E7 Proteins; Proteasome Endopeptidase Complex; Retinoblastoma Protein - metabolism; Tumors; Ubiquitins - metabolism; Viruses
• ISSN: 0008-5472; 1538-7445

Rb protein is a critical regulator of entry into the cell cycle, and loss of Rb function by deletions, mutations, or interaction with DNA viral oncoproteins leads to oncogenic transformation. We have shown that the human papilloma virus (HPV)-16 E7 gene is sufficient to induce the immortalization of mammary epithelial cells (MECs). Surprisingly, the steady-state level of Rb protein in these immortal cells was drastically decreased. Here, we used pulse-chase analysis to show that the in vivo loss of Rb protein in E7-immortalized MECs is a consequence of enhanced degradation. Expression of HPV16 E7 in a cell line with a temperature-sensitive mutation in the E1 enzyme of the ubiquitin pathway demonstrated that degradation of Rb was ubiquitin dependent. Treatment of E7-immortalized MECs with aldehyde inhibitors of proteasome-associated proteases led to a marked stabilization of Rb protein, particularly the hypophosphorylated form. Taken together, our results provide evidence for HPV-16 E7-induced enhanced degradation of Rb protein via a ubiquitin-proteasome pathway and suggest a second mechanism of oncogenic transformation by E7, in addition to its previously identified ability to sequester Rb from E2F. Our analyses also show that normal Rb levels are regulated by the ubiquitin-proteasome degradation pathway.